A novel orally active gonadotropin‐releasing hormone antagonist, relugolix, is a potential substitute for injectable GnRH antagonists in controlled ovarian stimulation in assisted...

por Hamada, Michiko, Horikawa, Michiharu, Ensaka, Chie, Enomoto, Megumi, Ishii, Rena, Toriumi, Rena, Tachibana, Naoyuki, Taketani, Yuji
Publicado 2021

The addition of dydrogesterone improves the outcomes of pregnant women with low progesterone levels when receiving vaginal progesterone alone as luteal support in HRT‐FET cycles

por Toriumi, Rena, Horikawa, Michiharu, Sato, Chie, Shimamura, Nagisa, Ishii, Rena, Terashima, Michiru, Hamada, Michiko, Tachibana, Naoyuki, Taketani, Yuji
Publicado 2023

Different anti‐Műllerian hormone (AMH) levels respond to distinct ovarian stimulation methods in assisted reproductive technology (ART): Clues to better ART outcomes

por Ishii, Rena, Tachibana, Naoyuki, Okawa, Riho, Enomoto, Megumi, Asami, Mai, Toriumi, Rena, Hamada, Michiko, Horikawa, Michiharu, Akiba, Yoko, Taketani, Yuji
Publicado 2019

Identifying a possible factor for the increased newborn size in singleton pregnancies after assisted reproductive technology using cryopreserved embryos, in comparison with fresh e...

por Ishii, Rena, Shoda, Akiko, Kubo, Michiyo, Okazaki, Satiko, Suzuki, Minori, Okawa, Riho, Enomoto, Megumi, Shitanaka, Manami, Fujita, Yoko, Nakao, Kazuki, Shimada, Nobutaka, Horikawa, Michiharu, Negishi, Hiroaki, Taketani, Yuji
Publicado 2018